European Georges Pompidou Hospital, APHP
Paris, 75908, France
NCT Number: NCT04256499
Acute water load test has been using to diagnose renal ability to excrete water for decades. Latest recommendations for the diagnosis of hyponatremia do not recommend performing such a test. The investigators aim at, retrospectively, study the value of acute water load test in patients suffering from a syndrome of inappropriate antidiuresis.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Paris, 75908, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The acute water load test consists in administering orally 20 mL/kg (of body weight) of water (ingested in less than 30 min) and then follow (during 4 to 6 hours) blood and urine parameters.
Time frame: any time after water load test from hour 2 to hour 6
Plasma sodium concentration (abnormal if <135mM)
Time frame: any time after water load test from hour 2 to hour 6
Plasma osmolality (abnormal if <280mOsm/kgH2O)
Time frame: after water load test from hour 0 to hour 6
Ratio between the excreted water (in urine) volume and the ingested one
Time frame: any time after water load test from hour 2 to hour 6
Minimum urine osmolality reached
Time frame: Value at hour 6 versus initial value (hour 0)
Variation of body weight during the test
European Georges Pompidou Hospital
Other
Water Load Test Value for Hyponatremia Due to a Syndrome of Inappropriate Antidiuresis (SIAD)
Acronym: WATERLINE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06277336
Brain Diseases, Central Nervous System Diseases
Basel, Switzerland
View Trial DetailsNCT03202667
Brain Diseases, Central Nervous System Diseases
Basel, Switzerland
View Trial DetailsNCT07528365
Brain Diseases, Central Nervous System Diseases
Turin, Piedmont, Italy, Italy
View Trial DetailsNCT00201994
Brain Diseases, Cardiovascular Diseases
Gustav Carus, Dresden, Germany
View Trial Details